Brief: Kintor Pharmaceutical Posts HY Loss & Total Comprehensive Loss Attributable RMB325.8 Mln
27/08/2021 16:15
Aug 27 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* HY LOSS AND TOTAL COMPREHENSIVE LOSS ATTRIBUTABLE RMB325.8
MILLION VERSUS LOSS OF RMB195.4 MILLION
Source text for Eikon: ID:nHKS3zhBjC
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint